InnovAge Holding Corp

InnovAge Holding Corp(INNV)の株式分析

$8.880

+0.030 (+0.34%)終値時点

Loading chart…
高値
8.960
始値
8.880
出来高加重平均価格
8.88
出来高
288.78K
時価総額
712.58M
安値
8.810
売買代金
2.57M
EV/EBITDA(TTM)
15.09

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.

www.innovage.com

AI分析 of InnovAge Holding Corp (INNV)

中立

InnovAge Holding Corp is currently trading at $8.85, which is below the analyst price target of $14, indicating potential upside. However, the stock has a low RSI of 28.335, suggesting it may be oversold, but recent insider selling has increased by 105.94%, which raises concerns about market confidence. The forward P/E ratio is 13.66, which is reasonable, but the recent secondary offering at $9.25 may dilute existing shares and negatively impact the stock price in the short term.

バリュエーション指標

InnovAge Holding Corp(INNV)の現在の予想PERは13.66で、5年平均は-108.19です。

予想PER

適正
5年平均 P/E
-108.19
現在のP/E
13.66
割高
968.96
割安
-1185.33

予想EV/EBITDA

適正
5年平均 EV/EBITDA
-7.89
現在のEV/EBITDA
15.09
割高
181.43
割安
-197.22

予想PSR

適正
5年平均 P/S
0.98
現在のP/S
1.04
割高
1.27
割安
0.69

Alphio AI による INNV の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%INNV

$4.78

シナリオ価格

基

基本

基本 · 50%INNV

$4.75

シナリオ価格

弱

弱気

弱気 · 25%INNV

$3.97

シナリオ価格

INNV を保有するクジラ

C

Coliseum Capital Management, LLC

+ を保有INNV

-26.24%

3か月リターン

イベントタイムライン

2026-09-23 (ET)

16:30:00

Major Averages Close Lower as 10-Year Treasury Yield Hits 5.13%

12:00:00

Major Averages Broadly Lower as Oil Rises Over 1%

2026-09-22 (ET)

22:00:00

Barclays, Goldman Sachs, and Wells Fargo Jointly Manage Offering Priced at $9.25

20:00:00

Dow Falls, Nasdaq Hits New Record Highs

17:00:00

Barclays, Goldman Sachs, and Wells Fargo Jointly Manage Offering

ニュース

INNV のよくある質問 — Alphio AI が回答

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

InnovAge Holding Corp is currently trading at $8.85, which is below the analyst price target of $14, indicating potential upside. However, the stock has a low RSI of 28.335, suggesting it may be oversold, but recent insider selling has increased by 105.94%, which raises concerns about market confidence. The forward P/E ratio is 13.66, which is reasonable, but the recent secondary offering at $9.25 may dilute existing shares and negatively impact the stock price in the short term.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める